ENDOSCOPIC ULTRASONOGRAPHY IN THE DIAGNOSIS AND STAGING OF PANCREATICADENOCARCINOMA - RESULTS OF A PROSPECTIVE-STUDY WITH COMPARISON TO ULTRASONOGRAPHY AND CT SCAN
L. Palazzo et al., ENDOSCOPIC ULTRASONOGRAPHY IN THE DIAGNOSIS AND STAGING OF PANCREATICADENOCARCINOMA - RESULTS OF A PROSPECTIVE-STUDY WITH COMPARISON TO ULTRASONOGRAPHY AND CT SCAN, Endoscopy, 25(2), 1993, pp. 143-150
Endoscopic ultrasonography (EUS) was compared to ultrasonography (US)
and CT scan (CT) in order to evaluate its role in the diagnosis and th
e locoregional spread assessment of pancreatic cancer. Sixty-four pati
ents suspected of pancreatic cancer were studied prospectively, and th
e results of imaging techniques were compared to histology and surgica
l exploration. There were 49 cases of pancreatic adenocarcinoma, 11 of
pancreatitis, 2 of common bile duct carcinoma, 1 lymphoma and 1 hepat
ocellular carcinoma with peripancreatic metastatic lymph nodes. EUS wa
s significantly more accurate (91 %) than CT (66 %) and US (64 %) for
diagnosis of pancreatic cancer. EUS was able to image all 7 cancers le
ss than 25 mm in diameter, US and CT only one. There were 4 false posi
tives with EUS which were all cases of pseudotumorous pancreatitis. Fo
r detecting lymph node involvement, EUS was significantly more sensiti
ve (62 %) and accurate (74 %) than US (8 % and 37 %) and CT (19 % and
42 %), respectively. Invaded lymph nodes adjacent to large tumors and
micrometastatic involvement were responsible for this lack of sensitiv
ity. EUS was significantly more sensitive (100 %) than CT (71 %) and U
S (17 %) for detecting venous involvement. The specificity of EUS was
lower (67 %) because of duodenal bulb stenosis and large tumors. In co
nclusion, this prospective and comparative study confirms that EUS is
an accurate tool for diagnosis and locoregional spread assessment of p
ancreatic cancer when performed in a reference center. EUS is of parti
cular interest for small tumors. However, EUS does not enable differen
tiation of pseudotumorous pancreatitis from adenocarcinoma.